Secret Vaccine Meeting: NIH Locks Doors on Adjuvant Deals
Published Date: 3/19/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 3-4, 2025, to review secret contract proposals for developing vaccine adjuvants. This affects small businesses competing for government research contracts and keeps sensitive info private. The meeting helps decide who gets funding to boost vaccine innovation, with no public access to protect trade secrets and personal data.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Closed Review Protects Trade Secrets
If you are a small business submitting an SBIR contract proposal for adjuvant development (Solicitation PHS 2025-1, NIH/NIAID 142), the review on April 3-4, 2025 will be closed and your confidential trade secrets and personal data will be kept private under 5 U.S.C. 552b(c)(4) and 552b(c)(6).
SBIR Award Decisions for Vaccine Adjuvants
On April 3-4, 2025, the NIAID Special Emphasis Panel will review and evaluate SBIR contract proposals under Solicitation PHS 2025-1 (NIH/NIAID 142) to decide which small businesses receive contracts for adjuvant development for vaccines.
Meeting Closed — No Public Access
The meeting on April 3-4, 2025 will be closed to the public, with no public access to the contract proposals or discussions, in order to protect trade secrets and personal information.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18191, Submission for OMB Review; 30-Day Comment Request Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
The National Institutes of Health (NIH) is asking for public feedback on their Data and Specimen Hub (DASH), which helps researchers share important health data. This is a quick 30-day review to make sure the information collection is clear and useful. If you’re involved in health research or data sharing, your input by October 8, 2026, can help shape how DASH works without costing extra money or time.
2026-17899, Proposed Collection; 60-Day Comment Request; Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report (Office of the Director)
The NIH wants your thoughts on their plan to keep track of animal research safety through yearly reports and assurances from institutions, both in the U.S. and abroad. This helps make sure labs follow the rules and protect animals, with no new costs or big changes expected. You’ve got until October 2, 2026, to share your feedback and help improve the process!
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
Previous / Next Documents
Previous: 2025-04466, Notice of Inventory Completion: U.S. Department of Agriculture, Forest Service, Deschutes National Forest, Bend, OR
The Deschutes National Forest finished checking its collection of Native American human remains and related items. They found a clear connection to certain Indian Tribes and Native Hawaiian groups. This means these items will be returned to the right communities, following important laws, with no cost or delays expected.
Next: 2025-04468, National Institute of Mental Health; Notice of Closed Meetings
The National Institute of Mental Health is holding two secret virtual meetings in April and May 2025 to review grant applications. These closed sessions protect private info and trade secrets while deciding who gets funding for mental health research. If you’re applying for grants, keep an eye on these dates—they’re key to the money decisions coming soon!